Atherectomy Devices Market Accelerates on Rising Peripheral Artery Disease Cases and Advancements in Image-Guided Technologies

The global Atherectomy Devices Market is poised for significant expansion as interventional cardiology and vascular surgery favor minimally invasive approaches to plaque removal. According to Vantage Market Research, the market was valued at USD 1.04 billion in 2024, and is projected to reach USD 2.485 billion by 2035, growing at a CAGR of around 8.25% over the forecast period. This growth is being driven by rising incidence of peripheral artery disease (PAD) and coronary artery disease (CAD), continuous innovation in device technologies, and increasing adoption of atherectomy in hospitals and surgical centers.

Key Takeaways

The atherectomy devices market is forecast to more than double in value by 2035, signaling strong demand from vascular and cardiac disease management.

Directional atherectomy devices are expected to maintain dominance due to their precise plaque excision capabilities.

Cardiovascular applications (coronary artery disease) represent a major share, though peripheral applications are key growth drivers as PAD prevalence rises.

Hospitals & surgical centers remain the primary end users, reflecting the procedural complexity and infrastructure needs for atherectomy.

North America leads the market by revenue today, but Asia Pacific is projected to be the fastest-growing region over the forecast period.

Regulatory complexity and cost remain challenges, but increasing reimbursement and clinical adoption are creating strong expansion opportunities.

Key Market Trends & Insights

1. Adoption of minimally invasive vascular procedures is accelerating, and atherectomy is increasingly favored for its precision and reduced trauma compared to traditional surgery.
2. Technological innovation is underway: directional, rotational, orbital, and laser atherectomy systems are being refined for better plaque removal, safety, and real-time imaging compatibility.
3. Aging populations, rising PAD and CAD prevalence, and increasing rates of diabetes are driving patient pools needing endovascular plaque modification.
4. Reimbursement reforms and favorable payer policies (especially for minimally invasive procedures) are helping to expand access.
5. Shift toward outpatient and hybrid surgical centers: hospitals and surgical suites are optimizing for device-based interventions, with atherectomy playing a central role.
6. Emerging markets in Asia Pacific are becoming key targets as healthcare infrastructure improves and demand for interventional vascular therapies grows.

Market Size & Forecast

2024: USD 1.04 billion.

2035 (Forecast): USD 2.485 billion.

CAGR (2025–2035): 8.25%.

The atherectomy devices market displays a competitive but specialized landscape. Key traits include:

1. Moderate concentration: Leading medical device companies such as Boston Scientific, Abbott, Medtronic, Philips, Avinger, and Cardiovascular Systems, Inc. (CSI) dominate with well-established vascular platforms and strong R&D.
2. High technical and regulatory barriers: Atherectomy devices require rigorous clinical validation, imaging integration, and quality manufacturing to ensure safety and efficacy.
3. Recurring demand: These devices support repeated use, maintenance, and follow-up interventions, especially in complex chronic vascular disease.
4. Innovation-driven: Continuous improvements in device design, imaging, and minimally invasive delivery drive differentiation among vendors.
5. Geographic dynamics: Growth is anchored in North America, but players are increasingly targeting Asia Pacific, Latin America, and other regions to expand reach.
6. Clinical adoption: The shift from open surgery to percutaneous interventions is enhancing adoption of atherectomy devices across hospitals and surgical centers.

Product Insights

The product segmentation highlights the diverse portfolio of solutions available in the market, ranging from basic offerings to advanced, specialized products designed for niche requirements. Each product category caters to different performance, functionality, and technology expectations of end users. Growth is driven by increasing innovation, improved materials, and the push for higher efficiency and reliability. Companies are focusing on product differentiation, cost-effectiveness, and enhanced features to capture a wider customer base, while premium product lines are gaining traction due to rising quality standards.

Application Insights

Application segmentation provides insights into the varied use cases across industrial, commercial, and consumer environments. Each application area has distinct operational needs, influencing product design, compliance requirements, and performance parameters. Demand patterns differ based on sector-specific challenges such as precision, speed, safety, or durability. Growth is driven by expanding industry verticals, technological advancements, and rising adoption of automated or digital solutions. As applications diversify, companies are focusing on tailored solutions that enhance user experience, optimize workflows, and improve overall operational efficiency.

End User Insights

End-user segmentation outlines the key customer groups adopting these products, including hospitals, industries, research facilities, commercial entities, or consumers, depending on the market. Each group has unique expectations regarding performance, cost, compliance, and ease of use. Market growth is influenced by rising investment in modernization, increasing awareness, and expanding application scope across sectors. Vendors aim to address end-user pain points through customization, service support, and value-added offerings. Understanding end-user dynamics helps companies refine strategies and target high-potential customer segments effectively.

Regional Insights

North America Market Trends

North America is the leading market for atherectomy devices, leveraging high healthcare spending, advanced vascular surgery infrastructure, and strong reimbursement policies. The U.S. especially supports widespread adoption of directional, rotational, and orbital atherectomy systems, driven by interventional cardiologists and vascular surgeons. Regulatory approvals and payer support further enhance device penetration. The region remains a hotbed for innovation and early adoption, giving major players a base for R&D and commercialization.

Europe Market Trends

In Europe, the atherectomy devices market is expanding steadily, supported by strong public and private cardiovascular care systems, high PAD burden, and growing need for minimally invasive interventions. European centers are adopting advanced atherectomy systems, especially for complex peripheral and coronary lesions, while emphasizing evidence-based outcomes, cost-effectiveness, and safety. Reimbursement frameworks and clinical guidelines continue to evolve, catalyzing adoption across major countries like Germany, France, and the UK.

Asia Pacific Market Trends

The Asia Pacific region is forecast to be the fastest-growing market for atherectomy devices. Rising prevalence of diabetes, cardiovascular disease, and peripheral artery disease, coupled with expanding healthcare infrastructure and increasing use of interventional cardiology, is fueling adoption. Local manufacturing, growing clinical expertise, and medical tourism are also contributing factors. As device makers scale into this region, they are tailoring product offerings and pricing to meet regional needs and regulatory environments.

Latin America Market Trends

In Latin America, the atherectomy market is emerging but showing strong promise. The burden of vascular disease (PAD, CAD), increasing urbanization, and improving access to minimally invasive therapies are driving demand. While capital costs and reimbursement remain barriers, public and private hospitals are beginning to adopt atherectomy devices. Regional partnerships and training initiatives are helping growers to penetrate this under-penetrated yet clinically vital vascular market.

Middle East & Africa Market Trends

The Middle East & Africa (MEA) region is still at a nascent stage for atherectomy device adoption, but growth potential is high. Major urban centers in GCC countries are investing in advanced cardiovascular care, including interventional vascular suites. However, broader adoption is hindered by infrastructure gaps, limited trained operators, and variable reimbursement. Companies entering this region are focusing on partnerships with academic hospitals, cost-effective devices, and training programs to build procedural volumes.

Top Key Players in the Atherectomy Devices Market

1. Boston Scientific Corporation
2. Cardiovascular Systems Inc.
3. Medtronic PLC
4. Avinger Inc.
5. Koninklijke Philips N.V.
6. Becton Dickinson and Company
7. Abbott
8. Cordis Corp.
9. Terumo Medical Corporation

These companies are investing in R&D, regulatory approvals, imaging-integrated systems, and global expansion to maintain and grow their leadership in this evolving field.

Recent Developments

In 2024, Boston Scientific announced the expansion of its Rotablator rotational atherectomy system portfolio, including a next-generation burr design to improve lesion crossing and reduce vessel trauma during peripheral and coronary interventions.

In 2025, Avinger, Inc. published early clinical data for its image-guided directional atherectomy system, demonstrating improved plaque removal and lower embolic risk, increasing clinician confidence in using atherectomy in complex lesions.

Report Scope

The market report provides a comprehensive analysis of industry dynamics, covering key trends, growth drivers, restraints, and emerging opportunities. It includes detailed segmentation by product, application, and end user, along with regional insights and competitive landscape evaluation. The study offers market size forecasts, technological developments, regulatory impacts, and investment outlook. The report aims to equip stakeholders with actionable intelligence for strategic decision-making, market entry, expansion planning, and identifying future growth potential.

Market Dynamics

Driver

A primary driver for the atherectomy devices market is the growing prevalence of vascular diseases, notably peripheral artery disease (PAD) and coronary artery disease (CAD), fueled by aging populations and lifestyle-related risk factors (diabetes, hypertension). At the same time, the strong clinical shift toward minimally invasive procedures encourages use of atherectomy as a key tool for plaque removal. The combination of rising disease burden and procedural preference supports sustained demand.

Restraint

Regulatory complexity and cost remain significant restraints. Atherectomy devices must navigate strict approval pathways, clinical validation, and safety testing. Capital investments for advanced devices (e.g., laser or image-guided systems) are high, and smaller hospitals may face budget constraints. In addition, concerns around procedural risk (embolization, vessel damage) and the need for specialized operator training can limit adoption in less developed healthcare settings.

Opportunity

Emerging markets, especially in Asia Pacific and Latin America, present a significant opportunity. Improving healthcare infrastructure, rising adoption of interventional cardiology, and increasing vascular disease awareness make these regions attractive. There is also potential for hybrid procedures, combining atherectomy with drug-coated balloons or stents, to improve outcomes and expand indications. Furthermore, incorporation of real-time imaging, robotics, and AI into atherectomy systems can open up new clinical applications and drive adoption.

Challenges

Key challenges include maintaining long-term clinical efficacy, reducing complication risks, and ensuring cost-effectiveness. Ensuring consistent reimbursement across different geographies and payers is difficult. Furthermore, building an evidence base to demonstrate superiority (or parity) of atherectomy over conventional angioplasty or stenting is resource-intensive. Scalability of training programs for interventionalists is also critical, as well as integrating newer technologies such as imaging-guided systems into everyday clinical workflows.

Report Segmentation

Based on Vantage Market Research:

1. By Product: Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices; Rotational Atherectomy Devices; Support Devices
2. By Application: Peripheral Vascular; Cardiovascular; Neurovascular
3. By End-User: Hospitals & Surgical Centers; Ambulatory Care Centers; Research Laboratories & Academic Institutes
4. By Region: North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Frequently Asked Questions

Q1: What was the global atherectomy devices market size in 2024?

A1: Approximately USD 1.04 billion, according to Vantage Market Research.

Q2: What is the projected market size by 2035 and its CAGR?

A2: The market is expected to reach USD 2.485 billion by 2035, with a CAGR of 8.25% from 2025–2035.

Q3: Which region currently dominates the atherectomy devices market?

A3: North America is the largest region in terms of market share, per Vantage data.

Q4: What are the major types of atherectomy devices?

A4: Major types include Directional, Rotational, Orbital, and Laser atherectomy systems, plus support devices.

Q5: Who are some of the leading companies in this market?

A5: Key players include Boston Scientific, Medtronic, Abbott Laboratories, Philips, Avinger, and Cardiovascular Systems, Inc.